Get the Stockscreener App
6.13
0.89%
-0.055
Immucell Corp stock is traded at $6.13, with a volume of 11,689.
It is down -0.89% in the last 24 hours and down -6.20% over the past month.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
See More
Previous Close:
$6.185
Open:
$6.145
24h Volume:
11,689
Relative Volume:
0.43
Market Cap:
$55.85M
Revenue:
$23.84M
Net Income/Loss:
$-3.81M
P/E Ratio:
-12.26
EPS:
-0.5
Net Cash Flow:
$-713.00K
1W Performance:
-3.77%
1M Performance:
-6.20%
6M Performance:
+19.96%
1Y Performance:
+63.47%
1-Day Range:
$6.1301
$6.4299
1-Week Range:
$5.99
$6.4299
52-Week Range:
$3.34
$7.60
Immucell Corp Stock (ICCC) Company Profile
Name
Immucell Corp
Sector
Industry
Phone
(207) 878-2770
Address
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
6.18 | 55.90M | 23.84M | -3.81M | -713.00K | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
382.52 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.70 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.88 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
670.61 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
295.02 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Immucell Corp Stock (ICCC) Latest News
ImmuCell Earnings: Animal Health Leader to Reveal Q2 2025 Financial Performance - Stock Titan
Full technical analysis of ImmuCell Corporation stockFree Weekly Setup With 3x Return Potential - Newser
Signal strength of ImmuCell Corporation stock in tech scannersIntraday Movement Recap and Chart Summary - Newser
Price action breakdown for ImmuCell CorporationLoss Limitation Strategy Based on Analysis - Newser
Understanding ImmuCell Corporation’s price movementSecure Entry Point Finder with Analysis - Newser
Using R and stats models for ImmuCell Corporation forecastingFundamental + Technical Combined Watchlist - Newser
Should I buy ImmuCell Corporation stock before earningsFree Fundamental + Technical Hybrid Stock Tips - Newser
What makes ImmuCell Corporation stock price move sharplyFree High Accuracy Alerts for ROI Traders - Newser
What is the risk reward ratio of investing in ImmuCell Corporation stockDiscover high-return stocks for your portfolio - Jammu Links News
Is ImmuCell Corporation a good long term investmentGet alerts on the hottest market movers - Jammu Links News
Is ImmuCell Corporation stock overvalued or undervaluedCapitalize on emerging trends for profits - Jammu Links News
How does ImmuCell Corporation compare to its industry peersSuperior investment outcomes - Jammu Links News
Is ImmuCell Corporation showing signs of accumulationShort Term Profit Strategy with Entry Cues - Newser
Regression analysis insights on ImmuCell Corporation performanceFree Weekly Hot Picks With Buy Confidence - Newser
Analyzing recovery setups for ImmuCell Corporation investorsMomentum Screener with Buy and Sell Areas - Newser
What to do if you’re stuck in ImmuCell CorporationFree Day Trading Signals With High Precision - Newser
Technical Models Detect Momentum Build in ImmuCell CorporationRisk Controlled Short Term Trade Plans Published - metal.it
Trend Reversal Possible in ImmuCell Corporation Charts IndicateFast Entry High Potential Stock Alerts Triggered - metal.it
How to interpret RSI for ImmuCell Corporation stockFree Early Entry Tips With Low Risk Zone - Newser
What is ImmuCell Corporation company’s growth strategyGet alerts on high-potential stock breakouts - Jammu Links News
What are analysts’ price targets for ImmuCell Corporation in the next 12 monthsAchieve exceptional returns with expert guidance - Jammu Links News
How does ImmuCell Corporation generate profit in a changing economyBuild a portfolio that stands the test of time - jammulinksnews.com
ImmuCell Upgraded to Outperform on Sales Surge & FDA Upside - MSN
What analysts say about ImmuCell Corporation stockFast-track wealth growth - jammulinksnews.com
What drives ImmuCell Corporation stock priceSuperior stock growth - jammulinksnews.com
How ImmuCell Corporation stock performs during market volatilityHigh Return Stock Alerts - Newser
ImmuCell Corporation Stock Analysis and ForecastBreakthrough investment results - Autocar Professional
The Zacks Analyst Blog Highlights Alphabet, Oracle, Shell, Fossil and ImmuCell - Yahoo Finance
Why ImmuCell Corporation stock attracts strong analyst attentionLow Risk Profit Ideas - Newser
Immucell Corp Stock (ICCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.54%
1.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):